secwatch.observer — SEC 8-K summary
======================================

Issuer:     MusclePharm Corp (—)
CIK:        0001415684
Form:       8-K
Filed at:   2023-01-11T23:59:59+00:00
Accession:  0001415684-23-000002
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 4.01
LLM model:  deepseek-v4-flash:cloud@v2

Auditor Moss Adams resigns; MusclePharm cites internal control weaknesses and going concern
--------------------------------------------------------------------------------

- Moss Adams resigned as independent accountant effective Jan 4, 2023.
- No disagreements with Moss Adams; however, material weaknesses in internal controls were reported.
- Moss Adams' April 2022 opinion included a going concern explanatory paragraph.
- Company restated 2021 annual and Q1 2022 financials; no filings made after March 31, 2022.
- Significant accounting staff turnover and lack of technical expertise cited as control deficiencies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1415684/000141568423000002/0001415684-23-000002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1415684/000141568423000002/Form8K.txt
  HTML page:      https://secwatch.observer/filing/0001415684-23-000002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer